1000181-36-1

Basic information

• Product Name: Spiro[4H-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid, 1,2,3,5-tetrahydro-, ethyl ester
• Synonyms: Spiro[4H-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid, 1,2,3,5-tetrahydro-, ethyl ester
• CAS NO: 1000181-36-1
• Molecular Formula: C₁₇H₂₁NO₂
• Molecular Weight: 271.35414
• Mol File: 1000181-36-1.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Spiro[4H-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid, 1,2,3,5-tetrahydro-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Spiro[4H-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid, 1,2,3,5-tetrahydro-, ethyl ester(1000181-36-1)
• EPA Substance Registry System: Spiro[4H-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid, 1,2,3,5-tetrahydro-, ethyl ester(1000181-36-1)

Safety Data

• Hazardous Substances Data: 1000181-36-1(Hazardous Substances Data)

Upstream product

• 813426-13-0 1,2,3,5-tetrahydrospiro[4H-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid 
• 64-17-5 ethanol 

Downstream Products

• 1000181-45-2 C₃₂H₃₀ClFN₂O₅ 

Relevant articles and documents

Next-generation spirobenzazepines: Identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies

We have continued to explore spirobenzazepines as vasopressin receptor antagonists to follow up on RWJ-339489 (2), which had advanced into preclinical development. Further structural modifications were pursued to find a suitable backup compound for human clinical studies. Thus, we identified carboxylic acid derivative 3 (RWJ-676070; JNJ-17158063) as a potent, balanced vasopressin V1a/V2 receptor antagonist with favorable properties for clinical development. Compound 3 is currently undergoing human clinical investigation.